跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Luveris - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Luveris
Approved
STANDARD
Luveris
Merck Serono SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f8a59e1f77ae6356
Company
Merck Serono SA
Type
Standard
Approval Details
Approval Id
f8a59e1f77ae6356
Drug Approval Philippines Name
Luveris
Product Name
Luveris
Registration Number
BR-824
Brand Name
Luveris
Generic Name
Lutropin Alfa
Dosage Form
Lyophilized Powder For Injection (SC)
Dosage Strength
75 IU (equivalent to 3.7 mcg/mL)
Manufacturer
Merck Serono SA
Importer
Merck, Inc.
Distributor
Merck, Inc.
Company Detail Path
/organization/merck-serono-sa
Importer Detail Path
/organization/merck-inc
Distributor Detail Path
/organization/merck-inc
Issuance Date
30 March 2021
Expiry Date
13 July 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f8a59e1f77ae6356
Type
Standard
Back to Philippines FDA Approvals